|
|
Volumn 31, Issue 19, 2013, Pages
|
|
Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma
a a a a a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B RAF KINASE;
DABRAFENIB;
DACARBAZINE;
IMATINIB;
LAPATINIB;
MITOGEN ACTIVATED PROTEIN KINASE;
SORAFENIB;
STEM CELL FACTOR;
VEMURAFENIB;
ANTINEOPLASTIC AGENT;
ARGININE;
BRAF PROTEIN, HUMAN;
CARBANILAMIDE DERIVATIVE;
DRUG DERIVATIVE;
IMIDAZOLE DERIVATIVE;
INDOLE DERIVATIVE;
LEUCINE;
NICOTINAMIDE;
OXIME;
SULFONAMIDE;
AGED;
ARTICLE;
AXILLARY LYMPH NODE;
CANCER LOCALIZATION;
CANCER SIZE;
CASE REPORT;
CELL VIABILITY;
COLORIMETRY;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SENSITIVITY;
DRUG TREATMENT FAILURE;
ENZYME ACTIVATION;
FEMALE;
GENE MUTATION;
HUMAN;
HUMAN CELL;
LUNG METASTASIS;
LUNG NODULE;
LYMPH NODE METASTASIS;
MELANOCYTE;
MELANOMA;
MELANOMA CELL;
MUTATION;
MUTATIONAL ANALYSIS;
POINT MUTATION;
PRIORITY JOURNAL;
SKIN ALLERGY;
SUBCUTANEOUS NODULE;
TREATMENT DURATION;
TREATMENT RESPONSE;
BACK;
CELL SURVIVAL;
DRUG ANTAGONISM;
DRUG EFFECT;
GENETICS;
LUNG TUMOR;
METASTASIS;
SIGNAL TRANSDUCTION;
SKIN TUMOR;
AGED;
ANTINEOPLASTIC AGENTS;
ARGININE;
BACK;
CELL SURVIVAL;
ENZYME ACTIVATION;
EXTRACELLULAR SIGNAL-REGULATED MAP KINASES;
FEMALE;
HUMANS;
IMIDAZOLES;
INDOLES;
LEUCINE;
LUNG NEOPLASMS;
MAP KINASE SIGNALING SYSTEM;
MELANOMA;
NIACINAMIDE;
OXIMES;
PHENYLUREA COMPOUNDS;
POINT MUTATION;
PROTO-ONCOGENE PROTEINS B-RAF;
SKIN NEOPLASMS;
SULFONAMIDES;
|
|
EID: 84890512515
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2012.46.1061; Document Type: Article |
|
Times cited : (46)
|
|
References (5)
|
